loader
Please Wait
Applying Filters...

AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 22117 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Allergan Aesthetics

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    PharmaCompass Sponsored Ads

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 ALLERGAN (3)

    filter

    01 TABLET;SUBLINGUAL (3)

    filter

    01 RX (3)

    filter

    01 SAPHRIS (3)

    filter

    01 Yes (3)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    ASENAPINE MALEATE

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET; SUBLINGUAL
    EQ 2.5MG BASE
    2015-03-12
    22117
    SAPHRIS
    RX
    Yes
    AB
    Abbvie CB

    78th STLE Annual Meeting

    Not Confirmed

    envelop Contact Supplier
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    ASENAPINE MALEATE

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET; SUBLINGUAL
    EQ 5MG BASE
    2009-08-13
    22117
    SAPHRIS
    RX
    Yes
    AB
    Abbvie CB

    78th STLE Annual Meeting

    Not Confirmed

    envelop Contact Supplier
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    ASENAPINE MALEATE

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET; SUBLINGUAL
    EQ 10MG BASE
    2009-08-13
    22117
    SAPHRIS
    RX
    Yes
    AB
    Abbvie CB

    78th STLE Annual Meeting

    Not Confirmed

    envelop Contact Supplier

    Looking for FDA Orange Book APPLICATION 22117

    Looking for FDA Orange Book APPLICATION 22117 3

    19

    Allergan Aesthetics, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is ASENAPINE MALEATE, with a corresponding application number 22117.

    Regulatory Information RX

    With a dosage strength EQ 2.5MG BASE

    Dosage Form Route TABLET; SUBLINGUAL

    Reference Listed Drug Yes

    Approved since 2015-03-12

    Therapeutic Equivalence (TE) Code AB

    18

    Allergan Aesthetics, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is ASENAPINE MALEATE, with a corresponding application number 22117.

    Regulatory Information RX

    With a dosage strength EQ 5MG BASE

    Dosage Form Route TABLET; SUBLINGUAL

    Reference Listed Drug Yes

    Approved since 2009-08-13

    Therapeutic Equivalence (TE) Code AB

    17

    Allergan Aesthetics, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is ASENAPINE MALEATE, with a corresponding application number 22117.

    Regulatory Information RX

    With a dosage strength EQ 10MG BASE

    Dosage Form Route TABLET; SUBLINGUAL

    Reference Listed Drug Yes

    Approved since 2009-08-13

    Therapeutic Equivalence (TE) Code AB

    Post Enquiry
    POST ENQUIRY